Long Noncoding RNAs: Clarity or Confusion?
Because They Are Such Elusive Prey, lncRNAs Have Yet to Emerge as Therapeutic Targets
Markets Expand for Single-Use Bioreactors
Biobags Offer Advantages Over Fixed-Tank Systems
The Challenges of Harmonizing Biomarker Data
Why Trial Success Depends on It
Top 10 Wall Street Losers of 2016
These Companies Lost the Most in a Down Year for Biopharma Stocks
- Aptamer Sciences
- #286, Postech Biotech Center, San 31 Hyoja-Dong
- Gyeongbuk 790-784
- Pohang ,
- SOUTH KOREA
Based on its aptamer technology platforms, Aptamer Sciences Inc. is a privately held biotech company focused on commercializing technologies for analysis of proteins. Aptamer Sciences is dedicated to develop the aptamer technologies to generate high quality aptamer and in broad applications of research, diagnosis and therapeutics.